The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Harry Suryapranata
Showing 1-8 of 8 articles
Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)
De Luca G,
Damen S,
Camaro C,
Benit E,
Verdoia M,
Rasoul S,
Liew H,
Polad J,
Ahmad W,
Zambahari R,
Postma S,
Kedhi E,
Suryapranata H
December 6, 2019 | 10.4244/EIJ-D-19-00539
Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial
Silber S,
Gutiérrez-Chico J-L,
Behrens S,
Witzenbichler B,
Wiemer M,
Hoffmann S,
Slagboom T,
Harald D,
Suryapranata H,
Nienaber C,
Naber C,
Chevalier B,
Serruys P
May 17, 2011 | 10.4244/EIJV7I1A13
Clinical results after coronary stenting with the GenousTM Bio-engineered R stentTM: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry
Silber S,
Damman P,
Klomp M,
Beijk M,
Grisold M,
Ribeiro E,
Suryapranata H,
Wójcik J,
Sim K,
Thijssen J,
de Winter R
February 21, 2011
Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial
Timmer J,
ten Berg J,
Heestermans A,
Dill T,
van Werkum J,
Dambrink J,
Suryapranata H,
Ottervanger J,
Hamm C,
van't Hof A
August 15, 2010
Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction
de Boer M,
Hoorntje J,
Gosselink A,
Suryapranata H,
van't Hof A
May 25, 2010
Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?
Dambrink J,
Debrauwere J,
van't Hof A,
Ottervanger J,
Gosselink M,
Hoorntje J,
de Boer M,
Suryapranata H
April 12, 2010
One year clinical follow-up of the XIENCE V Everolimus-eluting stent system in the treatment of patients with <i>de novo</i> native coronary artery lesions: the SPIRIT II study
Ruygrok P,
Desaga M,
Van den Branden B,
Rasmussen K,
Suryapranata H,
Dorange C,
Veldhof S,
Serruys P
November 20, 2007
Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial
Chevalier B,
Serruys P,
Silber S,
Garcia E,
Suryapranata H,
Hauptmann K-E,
Wijns W,
Schuler G,
Fath-Ordoubadi F,
Worthley SG,
Thuesen L,
Meredith I,
Bressers M,
Nagai H,
Paunovic D
February 20, 2007
1
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke